FDA Targets Misleading Influencers, Social Media Ads

FDA Targets Misleading Influencers, Social Media Ads
Under the Biden administration, federal drug regulators have homed in on misleading or imbalanced claims on social media, and early evidence shows those efforts will be a key focus in 2022. According to legal experts, pharmaceutical companies and medical device manufacturers that turn to influencers, celebrities and popular social media channels to promote their products should heed compliance warnings.

Read the source article at Welcome
2022-01-27 18:55:19